{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-24-013382","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.073404+00:00","generated_at":"2026-05-31T14:25:13.946448+00:00","sec_items":["7.01","3.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Alzamend Neuro regains Nasdaq bid price compliance; MVLS deficiency still pending","bullets":["Nasdaq notified Alzamend on July 30, 2024 that bid price compliance is regained after 10 consecutive days above $1.00.","Minimum Bid Price Requirement was met on July 29, 2024; matter is now closed.","MVLS deficiency remains: Alzamend must demonstrate compliance with $2.5M stockholder equity by September 23, 2024.","Company appealed delisting for MVLS; hearing panel granted extension to Sept 23, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-24-013382","json":"https://secwatch.observer/filing/0001214659-24-013382.json","markdown":"https://secwatch.observer/filing/0001214659-24-013382.md","text":"https://secwatch.observer/filing/0001214659-24-013382.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924013382/0001214659-24-013382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924013382/o7302498k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:25:13.946448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}